POVYX Mutual Fund

POVYX Mutual Fund

NAV$34.36
See how much of POVYX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jun 30, 2026

Net Assets
$104M
Expense Ratio
0.91%
Dividend Yield (Current)
2.37%
Holdings
251
Inception Date
Jul 12, 1996
Fund Family
Putnam Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+8.75%
1 Year+14.37%
3 Year+20.05%
5 Year+9.70%
10 Year+9.08%

Asset Allocation

Stocks: 98.87%
Bonds: 0.40%
Other: 0.72%
See how much of POVYX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
ASML:ASASML HOLDING NV3.92%
AZN:LNAstrazeneca Plc3.41%
8306:TKMitsubishi Ufj Financial Group Inc3.03%
ROG:SMRoche Holding Ag2.96%
SAF:PASafran Sa2.89%
Top 10 Concentration: 29.81%Report Date: Jun 30, 2026
Download all 251 holdings for POVYX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
2.37%
Latest Distribution
$0.74
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

POVYX Mutual Fund Overview

POVYX Mutual Fund (Putnam International Equity Fund Class Y) is managed by Putnam Investments with $104.3M in net assets. POVYX expense ratio is 0.91%, holding 251 positions across sectors including Consumer Staples, Industrials, Financials. Inception date: 1996-07-12.

POVYX performance shows a YTD return of 8.75%. The 1-year return is 14.37% and the 5-year return is 9.70%. POVYX dividend yield stands at 2.37%.

POVYX top holdings include ASML HOLDING NV (3.9%), Astrazeneca Plc (3.4%), Mitsubishi Ufj Financial Group Inc (3.0%), Roche Holding Ag (3.0%), Safran Sa (2.9%). Go to all POVYX holdings, POVYX sectors, or POVYX dividends.

POVYX can be compared against other funds. Use POVYX overlap to find shared positions, or POVYX vs another fund for a side-by-side view. POVYX alternatives are available via the screener, along with tax-loss harvesting opportunities.